Search

Search Constraints

You searched for: Author/Creator Estrach, T.

Search Results

2. T-cell receptor rearrangements in the skin and blood of patients in the PROCLIPI study: detection of clonal rearrangements in the skin (and blood) correlates with the B-class of MF and SS patients. (2019)

3. Systemic rituximab in the treatment of indolent primary cutaneous B-cell lymphomas. (2019)

4. An overall response in skin is associated with improved HRQoL in patients with MF/SS enrolled in the PROCLIPI study. (2019)

5. A study of quality of life in people with mycosis fungoides and Sézary syndrome. (28th February 2020)

6. 样肉芽肿和 Sézary 综合征患者生活质量研究. (28th February 2020)

7. Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma. (19th November 2019)

8. Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. (28th July 2019)

9. Should we be imaging lymph nodes at initial diagnosis of early‐stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international study. (10th September 2020)

10. Patients with primary cutaneous lymphoma are at risk for severe COVID‐19. Data from the Spanish Primary Cutaneous Lymphoma Registry. (2nd July 2021)